14 November 2014 in Child's Nervous System
30 June 2012 in Iranian Journal of Radiology
Primary non-Hodgkin’s lymphoma of the cranial vault is extremely rare. This case report presents a 42-year-old man with a painless subcutaneous scalp mass which extended intracranially associated with recent mild headache. Initial computed tomography and magnetic resonance imaging revealed two lesions emanating from the skull. Biopsy revealed a diagnosis of diffuse large B cell lymphoma (DLBCL). A thorough work-up revealed no other point of involvement. This case is concerned about considering lymphoma in the differential diagnosis of calvarial lesions with both intra- and extra cranial extensions but without obvious intervening bony destruction. Keywords: Lymphoma, B-Cell; Dura Mater; Cranial Vault
1 March 2015 in Operative Neurosurgery
BACKGROUND. Different and often complex routes are available to deal with jugular foramen tumors with extracranial extension.OBJECTIVE. To describe a no
11 June 2022 in The Neurohospitalist
Cyst enlargement with progressive symptoms in spinal intradural Neurocysticercosis (NCC) is an uncommon finding after effective treatment of NCC. Neither imaging nor clinical presentation is sufficient to differentiate a sterile arachnoid cyst from recurrence of NCC. We present a case of symptomatic spinal intradural cyst enlargement 16 years after successful treatment of intracranial and spinal NCC with anti-helminthics.
1 January 2019 in International Journal of Neurosurgery
Flow diversion is an endovascular technique for embolization of intracranial aneurysms using a semi-porous stent to that redirects blood flow away from the aneurysm and is a scaffold for vessel remodeling. With flow diversion, aneurysms close slowly over 6-12 months as endothelial growth into the stent covers the neck of the aneurysm. Flow diversion is the preferred treatment for unruptured, large, paraclinoid aneurysms, which are otherwise challenging to treat with conventional open surgical or endovascular techniques. Post-embolization perianeurysmal edema (PAE) is an uncommon complication that occurs weeks to months after embolization and manifests as brain parenchymal edema surrounding the treated aneurysm. The clinical presentation is varied and includes headache, seizure or focal neurologic deficit. Frequently, PAE is misdiagnosed as an embolic stroke, which is a more common post-embolization complication and has some clinical and imaging overlap. PAE can be differentiated from ischemia by the absence of restricted diffusion and aneurysm wall enhancement on post-contrast Magnetic Resonance Imaging (MRI). PAE was initially described following coil embolization, but has subsequently been observed after flow diversion alone or with adjunctive coiling. Post-embolization PAE presumably results from rapid aneurysm thrombosis, endothelial cell necrosis, and the ensuing inflammatory reaction, which spreads to the adjacent brain parenchyma. Early recognition of PAE is critical to initiate appropriate therapy.
23 September 2008 in Journal of Neurological Surgery Part B: Skull Base
Introduction: Glomus jugulare tumors are encapsulated, slow-growing , highly vascular, and locally invasive tumors.These tumors arise from paraganglion cells and they are histologically benign. The purpose of this study was to evaluate the effect of gamma knife radiosurgery (GKRS) on local tumor control. Methods: Thirty-five patients with histologically confirmed glomus jugulare underwent GKRS either as primary or adjuvant treatment. In 83% of patients, GKRS was the sole treatment and the remainder had undergone microsurgery.The tumors' volumes were between 1.7 and 23 mL, and gamma knife treatment was performed by means of 13 to 23 grays at 35 to 70% marginal isodose.The median follow-up period after radiosurgery was 2 years. Results: In all patients tumor size decreased or remained unchanged. No patient had tumor growth outside the prescribed treatment volume.The major complication has been peritumoral brain edema. Conclusions: The finding of our study shows that GKRS is an important option for glomus jugulare tumors either as primary or adjunctive treatment, although longer follow-up is needed to evaluate long-term outcomes.